Content area

Abstract

Ankylosing spondylitis (AS) is the historic term used for decades for the HLA-B27-associated inflammatory disease affecting mainly the sacroiliac joints (SIJ) and spine. Classification criteria for AS have radiographic sacroiliitis as a dominant characteristic. However, with the availability of MRI of SIJ, it could be demonstrated that the disease starts long before definite SIJ changes become visible on radiographs. The Assessment of SpondyloArthritis international Society, representing a worldwide group of experts reached consensus on changes in the nomenclature pertaining to axial spondyloarthritis (axSpA), such as the terminology of diagnosis and of assessment of disease activity tools. These are important changes in the field, as experts in axSpA are now in agreement that the term axSpA is the overall term for the disease. A further differentiation, of which radiographic versus non-radiographic is only one aspect, may be relevant for research purposes. Another important decision was that the terms AS and radiographic axSpA (r-axSpA) can be used interchangeably, but that the preferred term is r-axSpA. Based on the decision that axSpA is the correct terminology, a proposal was made to officially change the meaning of the ASDAS acronym to ‘Axial Spondyloarthritis Disease Activity Score’. In addition, for simplification it was proposed that the term ASDAS (instead of ASDAS-CRP) should be preferred and applied to the ASDAS calculated with C reactive protein (CRP). It is hoped that these changes will be used consequently for education, in textbooks, manuscripts and presentations.

Details

Title
Goodbye to the term ‘ankylosing spondylitis’, hello ‘axial spondyloarthritis’: time to embrace the ASAS-defined nomenclature
Author
Désirée van der Heijde 1   VIAFID ORCID Logo  ; Molto, Anna 2   VIAFID ORCID Logo  ; Sofia Ramiro 3   VIAFID ORCID Logo  ; Braun, Jürgen 4   VIAFID ORCID Logo  ; Dougados, Maxime 5   VIAFID ORCID Logo  ; van Gaalen, Floris A 1   VIAFID ORCID Logo  ; Gensler, Lianne S 6   VIAFID ORCID Logo  ; Inman, Robert D 7   VIAFID ORCID Logo  ; Landewé, Robert B M 8   VIAFID ORCID Logo  ; Marzo-Ortega, Helena 9   VIAFID ORCID Logo  ; Navarro-Compán, Victoria 10   VIAFID ORCID Logo  ; Phoka, Andri 11 ; Poddubnyy, Denis 12   VIAFID ORCID Logo  ; Protopopov, Mikhail 12   VIAFID ORCID Logo  ; Reveille, John 13   VIAFID ORCID Logo  ; Rudwaleit, Martin 14   VIAFID ORCID Logo  ; Sampaio-Barros, Percival 15 ; Sepriano, Alexandre 16   VIAFID ORCID Logo  ; Sieper, Joachim 12   VIAFID ORCID Logo  ; Filip E Van den Bosch 17   VIAFID ORCID Logo  ; van der Horst-Bruinsma, Irene 18 ; Machado, Pedro M 19 ; Baraliakos, Xenofon 4   VIAFID ORCID Logo 

 Rheumatology, Leiden University Medical Center, Leiden, The Netherlands 
 Rheumatology, Hospital Cochin, Paris, France; Université Paris-Cité, INSERM U1153, Paris, France 
 Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; Rheumatology, Zuyderland Medical Centre, Heerlen, The Netherlands 
 Rheumazentrum Ruhrgebiet, Ruhr University Bochum, Herne, Germany 
 Hopital Cochin, Rheumatology, Université Paris Descartes Faculté de Médecine, Paris, France 
 Medicine/Rheumatology, University of California, San Francisco, California, USA 
 Schroeder Arthritis Institute, University Health Network, University of Toronto, Toronto, Ontario, Canada 
 Rheumatology, Zuyderland Medical Centre, Heerlen, The Netherlands; Rheumatology, Amsterdam University Medical Center, Amsterdam, The Netherlands 
 NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust and Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK 
10  Rheumatology, University Hospital La Paz, IdiPaz, Madrid, Spain 
11  ASIF, London, UK 
12  Gastroenterology, Infectious Diseases and Rheumatology (including Nutrition Medicine), Charité Universitätsmedizin Berlin, Berlin, Germany 
13  Rheumatology, University of Texas McGovern Medical School, Houston, Texas, USA 
14  Internal Medicine and Rheumatology, Klinikum Bielefeld Rosenhöhe, Bielefeld, Germany 
15  Rheumatology, Faculdade de Medicina da Universidade de São Paulo e Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, Brazil 
16  Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; Nova Medical School, Universidade Nova de Lisboa, Lisboa, Portugal 
17  Rheumatology, Ghent University Hospital, Gent, Belgium; Internal Medicine and Pediatrics, VIB-UGent Center for Inflammation Research, Ghent University, Gent, Belgium 
18  Department of Rheumatology, Radboud University Medical Centre, Nijmegen, The Netherlands 
19  Rheumatology and Neuromuscular Diseases, University College London, National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre, London, UK; NHS Foundation Trust, London, UK; Rheumatology, Norhwick Park Hospital, London North West University Healthcare NHS Trust, London, UK 
Pages
547-549
Section
Viewpoint
Publication year
2024
Publication date
May 2024
Publisher
Elsevier Limited
ISSN
00034967
e-ISSN
14682060
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3035424358
Copyright
© 2024 Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ on behalf of EULAR.